ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Metrics to compare | ZIVO | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipZIVOPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.2x | −0.9x | 12.2x | |
PEG Ratio | 0.09 | −0.02 | 0.03 | |
Price/Book | −31.9x | 1.5x | 1.5x | |
Price / LTM Sales | 424.1x | 0.2x | 0.9x | |
Upside (Analyst Target) | - | 84.0% | 17.7% | |
Fair Value Upside | Unlock | 26.4% | 11.3% | Unlock |